4 recruiting, 3 active not recruiting, 2 completed, 2 not yet recruiting. 4 Phase 2, 3 Not applicable, 2 Phase 1, 1 Phase 3, 1 Phase 4.
Follow Hypopharyngeal Carcinoma: new trials by email Literature Review of Hypopharyngeal Carcinoma trials Research Report on Hypopharyngeal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers Electronic Health Record Review, Fentanyl, Laryngoscopy - Head and Neck Carcinoma, Hypopharyngeal Carcinoma | Phase 4 | Recruiting | OHSU Knight Cancer Institute | 58 | 2026-09-22 | 2026-10-05 |
| Thermotherapy for Head and Neck Cancer Patients Thermotherapy, Radiotherapy, Concurrent chemoradiation - Head and Neck Cancer, Oropharyngeal Carcinoma | Phase 1 | Recruiting | Erasmus Medical Center | 30 | 2026-09-01 | 2026-09-02 |
| Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma Finolizumab, Albumin-Bound Paclitaxel /nab-Paclitaxel, Cisplatin - Hypopharyngeal Carcinoma | Phase 2 | Recruiting | Eye & ENT Hospital of Fudan University | 116 | 2025-12-22 | 2025-12-23 |
| Thermotherapy for Locally Advanced Head and Neck Cancer Thermotherapy, radiotherapy - Head and Neck Cancer, Oropharyngeal Carcinoma | Phase 1 | Active not recruiting | Erasmus Medical Center | 2 | 2025-05-01 | 2026-09-02 |
| Comparing Neoadjuvant Chemotherapy Combined With PD-1 Inhibitor Versus Neoadjuvant Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Carcinoma Neoadjuvant Chemotherapy (NACT), Neoadjuvant and maintenance Tislelizumab, Concurrent chemo-radiotherapy (CCRT) - Laryngeal Carcinoma, Hypopharyngeal Carcinoma | Phase 3 | Not yet recruiting | Fudan University | 168 | 2025-04-28 | 2025-05-08 |
| Salvage Surgery in Recurrent Hypopharyngeal Carcinoma: an Observational Single-institutional Study From 1998 Hypopharyngeal Carcinoma | Active not recruiting | Fondazione IRCCS Policlinico San Matteo di Pavia | 100 | 2025-03-18 | 2025-12-19 | |
| The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma Docetaxel, Cisplatin, Capecitabine - Hypopharyngeal Carcinoma | Not applicable | Recruiting | Eye & ENT Hospital of Fudan University | 111 | 2022-11-01 | 2025-12-30 |
| Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study Cisplatin, Intensity-Modulated Proton Therapy, Quality-of-Life Assessment - Head and Neck Carcinoma, Head and Neck Carcinoma of Unknown Primary | Phase 2 | Active not recruiting | Mayo Clinic | 174 | 2022-02-16 | 2026-07-16 |
| Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment Medical Device Usage and Evaluation, Consultation, Exercise Intervention - Head and Neck Carcinoma, Hypopharyngeal Carcinoma | Not applicable | Completed | Thomas Jefferson University | 12 | 2021-03-28 | 2025-05-22 |
| Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma Docetaxel, Cisplatin, Capecitabine - Hypopharyngeal Carcinoma, Immunotherapy | Phase 2 | Unknown | Eye & ENT Hospital of Fudan University | 51 | 2020-05-21 | 2023-08-09 |
| Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer Neck dissection followed by radiotherapy(50Gy) according to risk factors, Definitive radiotherapy - Hypopharyngeal Carcinoma | Not applicable | Not yet recruiting | Tianjin Medical University Cancer Institute and Hospital | 120 | 2018-01-01 | 2017-12-12 |
| Interest of MRI in Preoperative Staging for the Laryngeal and Hypopharyngeal Cancer Pharyngo laryngeal MRI - Hypopharyngeal Carcinoma, Laryngeal Carcinoma | Completed | Hospices Civils de Lyon | 73 | 2017-03-23 | 2020-04-03 | |
| Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy Doxepin Hydrochloride, Placebo, Quality-of-Life Assessment - Esophageal Carcinoma, Hypopharyngeal Carcinoma | Phase 2 | Terminated | Mayo Clinic | 5 | 2014-04-14 | 2019-10-01 |
Hypopharyngeal Neoplasms (13) · Laryngeal Neoplasms (8) · Mouth Neoplasms (5) · Oropharyngeal Neoplasms (5) · Head and Neck Neoplasms (3) · Squamous Cell Carcinoma of Head and Neck (3) · Hyperthermia (2) · Paranasal Sinus Neoplasms (2) · Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Lung Neoplasms (1) · Lymphatic Metastasis (1) · Lymphoma (1) · Maxillary Sinus Neoplasms (1) · Mesothelioma (1)
Neoplasms (13) · Neoplasms by Site (13) · Otorhinolaryngologic Diseases (13) · Otorhinolaryngologic Neoplasms (13) · Pharyngeal Diseases (13) · Pharyngeal Neoplasms (13) · Stomatognathic Diseases (13) · Head and Neck Neoplasms (10) · Laryngeal Diseases (8) · Respiratory Tract Diseases (8) · Respiratory Tract Neoplasms (8) · Mouth Diseases (5) · Neoplasms by Histologic Type (4) · Neoplasms, Glandular and Epithelial (4) · Carcinoma (3)
Cisplatin (4) · Surgical Procedures, Operative (4) · Capecitabine (2) · Chemoradiotherapy (2) · Diathermy (2) · Docetaxel (2) · Hyperthermia, Induced (2) · Radiotherapy (2) · 1,2-diaminocyclohexaneplatinum II citrate (1) · 130-nm albumin-bound paclitaxel (1) · Adjuvants, Pharmaceutic (1) · Albumin-Bound Paclitaxel (1) · Behavior Therapy (1) · Doxepin (1) · Fentanyl (1)
Eye & ENT Hospital of Fudan University (3) · Erasmus Medical Center (2) · Mayo Clinic (2) · Fondazione IRCCS Policlinico San Matteo di Pavia (1) · Fudan University (1) · Hospices Civils de Lyon (1) · OHSU Knight Cancer Institute (1) · Thomas Jefferson University (1) · Tianjin Medical University Cancer Institute and Hospital (1)
China (5) · United States (4) · Netherlands (2) · France (1) · Italy (1)
Michiel Kroesen, MD, Dr. (2) · Ming Zhang, PhD (2) · Liang Zhou, PhD. (1) · Ryan N Hellums (1) · Scott C. Lester, M.D. (1) · Terence Sio (1) · Xudong Wang, Ph.D (1) · Yu Wang, M.D., professor, Chief (1)
P30CA015083 (1)